192 related articles for article (PubMed ID: 38157077)
21. Minimally invasive transanal surgery is safe after incomplete polypectomy of low risk T1 rectal cancer: a systematic review.
de Jong GM; Hugen N
Colorectal Dis; 2019 Oct; 21(10):1112-1119. PubMed ID: 31074574
[TBL] [Abstract][Full Text] [Related]
22. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
Alhanafy MK; Park SS; Park SC; Park B; Kim MJ; Sohn DK; Chang HJ; Oh JH
Dis Colon Rectum; 2020 Nov; 63(11):1500-1510. PubMed ID: 33044291
[TBL] [Abstract][Full Text] [Related]
23. Short- and long-term outcomes in ypT2 rectal cancer patients after neoadjuvant therapy and local excision: a multicentre observational study.
Peltrini R; Castiglioni S; Imperatore N; Ortenzi M; Rega D; Romeo V; Caracino V; Liberatore E; Basti M; Santoro E; Bracale U; Delrio P; Mucilli F; Guerrieri M; Corcione F
Tech Coloproctol; 2023 Jan; 27(1):53-61. PubMed ID: 36239872
[TBL] [Abstract][Full Text] [Related]
24. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
[TBL] [Abstract][Full Text] [Related]
25. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
26. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy.
Mazaki J; Tsukamoto S; Miyake M; Moritani K; Sakamoto R; Shida D; Kanemitsu Y
Dis Colon Rectum; 2021 Jan; 64(1):71-80. PubMed ID: 33306533
[TBL] [Abstract][Full Text] [Related]
27. Local excision results in comparable survival to radical resection for early-stage rectal carcinoid.
Ezekian B; Adam MA; Turner MC; Gilmore BF; Freischlag K; Leraas HJ; Mantyh CR; Migaly J
J Surg Res; 2018 Oct; 230():28-33. PubMed ID: 30100036
[TBL] [Abstract][Full Text] [Related]
28. Local Excision Versus Radical Resection for 1- to 2-cm Neuroendocrine Tumors of the Rectum: A National Cancer Database Analysis.
Fields AC; Saadat LV; Scully RE; Davids JS; Goldberg JE; Bleday R; Melnitchouk N
Dis Colon Rectum; 2019 Apr; 62(4):417-421. PubMed ID: 30394988
[TBL] [Abstract][Full Text] [Related]
29. A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.
Simillis C; Khatri A; Dai N; Afxentiou T; Jephcott C; Smith S; Jadon R; Papamichael D; Khan J; Powar MP; Fearnhead NS; Wheeler J; Davies J
Crit Rev Oncol Hematol; 2023 Mar; 183():103927. PubMed ID: 36706968
[TBL] [Abstract][Full Text] [Related]
30. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
[TBL] [Abstract][Full Text] [Related]
31. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
[No Abstract] [Full Text] [Related]
32. Completion Total Mesorectal Excision After Transanal Local Excision of Early Rectal Cancer: A Systematic Review and Meta-analysis.
Wyatt JNR; Powell SG; Altaf K; Barrow HE; Alfred JS; Ahmed S
Dis Colon Rectum; 2022 May; 65(5):628-640. PubMed ID: 35143429
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant radiotherapy for rectal cancer management.
Feeney G; Sehgal R; Sheehan M; Hogan A; Regan M; Joyce M; Kerin M
World J Gastroenterol; 2019 Sep; 25(33):4850-4869. PubMed ID: 31543678
[TBL] [Abstract][Full Text] [Related]
34. Predictors of Positive Circumferential Resection Margin in Rectal Cancer: A Current Audit of the National Cancer Database.
Simon HL; de Paula TR; Profeta da Luz MM; Kiran RP; Keller DS
Dis Colon Rectum; 2021 Sep; 64(9):1096-1105. PubMed ID: 33951688
[TBL] [Abstract][Full Text] [Related]
35. Long-term results of local excision for T1 rectal carcinoma: the experience of two colorectal units.
Lebedyev A; Tulchinsky H; Rabau M; Klausner JM; Krausz M; Duek SD
Tech Coloproctol; 2009 Sep; 13(3):231-6. PubMed ID: 19644648
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of survival and functional outcomes after total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery.
Hajibandeh S; Hajibandeh S; Matthews J; Palmer L; Maw A
Surgery; 2020 Sep; 168(3):486-496. PubMed ID: 32620303
[TBL] [Abstract][Full Text] [Related]
37. Non-inferiority multicenter prospective randomized controlled study of rectal cancer T
Serra-Aracil X; Pericay C; Golda T; Mora L; Targarona E; Delgado S; Reina A; Vallribera F; Enriquez-Navascues JM; Serra-Pla S; Garcia-Pacheco JC;
Int J Colorectal Dis; 2018 Feb; 33(2):241-249. PubMed ID: 29234923
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Tumour Distance From the Anal Verge on Clinical Management and Outcomes in Patients Having a Curative Resection for Rectal Cancer.
Khan MAS; Ang CW; Hakeem AR; Scott N; Saunders RN; Botterill I
J Gastrointest Surg; 2017 Dec; 21(12):2056-2065. PubMed ID: 28924962
[TBL] [Abstract][Full Text] [Related]
39. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
[TBL] [Abstract][Full Text] [Related]
40. Comparing neoadjuvant therapy followed by local excision to total mesorectal excision in the treatment of early stage rectal cancer: a systematic review and meta-analysis of randomised clinical trials.
Lynch P; Ryan OK; Donnelly M; Ryan ÉJ; Davey MG; Reynolds IS; Creavin B; Hanly A; Kennelly R; Martin ST; Winter DC
Int J Colorectal Dis; 2023 Nov; 38(1):263. PubMed ID: 37924372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]